Leading immunotherapy specialists in Israel include Prof. Dr. Ofer Merimsky and Dr. Ido Wolf at Sourasky Medical Center. These experts hold prestigious European Society for Medical Oncology (ESMO) roles. They lead advanced clinical trials for melanoma, sarcoma, and lung cancer using modern genomic profiling.
- Prof. Ofer Merimsky: Leads sarcoma research at Sourasky Medical Center with over 25 years of experience.
- Dr. Ari Raphael: Principal investigator for immunotherapy trials specializing in T-cell sequencing and liquid biopsies.
- Dr. Dvora Blumental: Directs neuro-oncology immunotherapy services after training at Memorial Sloan-Kettering Cancer Center.
- Dr. David Sarid: Senior oncologist at Sourasky with specialized cancer urology training from Oxford University.
Bookimed Expert Insight: Data shows a strong trend of specialization within immunotherapy in Israel. For example, Dr. Ari Raphael focuses on genomic profiling for lung cancer at Sourasky. Meanwhile, Dr. Sonnenblick Amir specializes in Keytruda for breast cancer. Families seeking pediatric care often choose Dr. Dror Levin, who trained at Italy's top bone oncology center. Consultations with these experts typically range from $750 to $1,050.
Patient Consensus: Patients note that Israeli centers offer much faster access to clinical trials than other countries. Many were surprised by the multidisciplinary approach where teams of specialists collaborate on one case. Those traveling to Jerusalem or Tel Aviv feel more involved in their treatment decisions because of the clear communication from the medical staff.
